New program aims to boost HPV vaccine uptake in teen girls

NCT ID NCT07562984

Not yet recruiting Knowledge-focused Sponsor: The Children's Hospital of Zhejiang University School of Medicine Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a comprehensive program to help adolescent girls aged 9-17 and their parents make informed decisions about the HPV vaccine. The program includes educational materials, shared decision-making conversations, and reminders. Researchers will compare vaccination rates and decision-making quality between those who receive the program and those who get standard care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: behavioral intervention (education, shared decision-making, reminders)
What this could lead to: If successful, this could provide a practical, evidence-based program to increase HPV vaccination rates among adolescent girls.
What could go wrong: This is an early-stage behavioral study with 300 participants, so results may not apply broadly. The intervention may not significantly change vaccination behavior.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BIOPSYCHOSOCIAL MODEL are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Vaccination Hesitancy human papilloma virus infection prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BIOPSYCHOSOCIAL MODEL HPV VACCINATION HESITANCY

More trials for these conditions

Other studies related to the condition(s) this trial covers.